8-iso-PGE2

8-iso-pge2 is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 323 references associated with 8-iso-PGE2 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 8-iso-PGE2

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 8-iso-PGE2

MeSH term MeSH ID Detail
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Brain Ischemia D002545 89 associated lipids
Pre-Eclampsia D011225 16 associated lipids
Premature Birth D047928 6 associated lipids
Total 5

NCBI Entrez Crosslinks

All references with 8-iso-PGE2

Download all related citations
Per page 10 20 50 100 | Total 67
Authors Title Published Journal PubMed Link
Brault S et al. Selective neuromicrovascular endothelial cell death by 8-Iso-prostaglandin F2alpha: possible role in ischemic brain injury. 2003 Stroke pmid:12624307
Nakamura K et al. Effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F2 alpha on the release of noradrenaline from the isolated rat stomach. 2003 Eur. J. Pharmacol. pmid:12787833
Weber TJ and Markillie LM Regulation of activator protein-1 by 8-iso-prostaglandin E2 in a thromboxane A2 receptor-dependent and -independent manner. 2003 Mol. Pharmacol. pmid:12695536
Huber J et al. The isoprostane 8-iso-PGE2 stimulates endothelial cells to bind monocytes via cyclic AMP- and p38 MAP kinase-dependent signaling pathways. 2003 Antioxid. Redox Signal. pmid:12716476
Wood LG et al. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. 2003 Am. J. Clin. Nutr. pmid:12499335
Cowley EA Isoprostane-mediated secretion from human airway epithelial cells. 2003 Mol. Pharmacol. pmid:12869634
Tintut Y et al. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. 2002 J. Biol. Chem. pmid:11827970
Wood LG et al. Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients. 2002 Am. J. Clin. Nutr. pmid:11916752
Janssen LJ and Tazzeo T Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature. 2002 J. Pharmacol. Exp. Ther. pmid:12023538
Catalli A et al. Receptors and signaling pathway underlying relaxations to isoprostanes in canine and porcine airway smooth muscle. 2002 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12376370